Squarepoint’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-113,437
| Closed | -$527K | – | 3181 |
|
|
2021
Q1 | $527K | Buy |
113,437
+52,219
| +85% | +$243K | ﹤0.01% | 1488 |
|
|
2020
Q4 | $202K | Sell |
61,218
-1,427
| -2% | -$4.71K | ﹤0.01% | 2135 |
|
|
2020
Q3 | $207K | Sell |
62,645
-82,115
| -57% | -$271K | ﹤0.01% | 1916 |
|
|
2020
Q2 | $488K | Buy |
+144,760
| New | +$488K | 0.01% | 1319 |
|
|
2020
Q1 | – | Sell |
-17,254
| Closed | -$104K | – | 2604 |
|
|
2019
Q4 | $104K | Buy |
17,254
+5,345
| +45% | +$32.2K | ﹤0.01% | 2245 |
|
|
2019
Q3 | $90K | Buy |
+11,909
| New | +$90K | ﹤0.01% | 2098 |
|
|
2019
Q2 | – | Sell |
-24,453
| Closed | -$133K | – | 2660 |
|
|
2019
Q1 | $133K | Buy |
+24,453
| New | +$133K | ﹤0.01% | 1956 |
|
|
2018
Q4 | – | Sell |
-14,861
| Closed | -$121K | – | 2304 |
|
|
2018
Q3 | $121K | Buy |
14,861
+1,119
| +8% | +$9.11K | ﹤0.01% | 1853 |
|
|
2018
Q2 | $134K | Buy |
+13,742
| New | +$134K | ﹤0.01% | 1609 |
|
|
2018
Q1 | – | Sell |
-19,843
| Closed | -$248K | – | 2259 |
|
|
2017
Q4 | $248K | Buy |
+19,843
| New | +$248K | ﹤0.01% | 1641 |
|